Targeting SLAMF3 to treat multiple myeloma

DISEASE CATEGORY: Cancer

INDICATION: Multiple myeloma (MM)

Inhibiting SLAMF3, a receptor to B and T cells, could

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE